Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Mirati Therapeutics, Inc. (MRTX)

« Back to company index

MRTX Chatter Timeline

Stock Ticker for MRTX

Most Active Tweeters for MRTX

UserTweets
@Gambiste1 6
@AmericanBanking 3
@stockmktgenius 3
@alphabyday 3
@WeekHerald 2

Recent Tweets for MRTX

InsiderAlertsIA @InsiderAlertsIA
$MRTX: New Insider Filing on 10%+ Owner MVA INVESTORS, LLC: https://t.co/v4MstmsXQL
July 15th 2019, 4:07pm
confcalltran @confcalltran
Major owner of Mirati Therapeutics, Inc. just disposed of 5,547 shares https://t.co/7qKekDgA85 $MRTX
July 15th 2019, 4:07pm
ConsumerFeed @ConsumerFeed
Mirati Therapeutics $MRTX PT Raised to $101.00 https://t.co/mPOOT3Fkzl
July 14th 2019, 4:07am
TickerReport @TickerReport
JPMorgan Chase & Co. Boosts Mirati Therapeutics $MRTX Price Target to $101.00 https://t.co/irXRYqkC0e
July 14th 2019, 4:07am
AmericanBanking @AmericanBanking
Mirati Therapeutics $MRTX PT Raised to $101.00 at JPMorgan Chase & Co. https://t.co/nPQQL6LEDW #stocks
July 12th 2019, 11:07am
Gambiste1 @Gambiste1
RT @BACScoreChanges: #MiratiTherapeutics $MRTX BidaskScore is Downgraded to Bought https://t.co/uZulUdOfhj
July 12th 2019, 4:07am
BACScoreChanges @BACScoreChanges
#MiratiTherapeutics $MRTX BidaskScore is Downgraded to Bought https://t.co/uZulUdOfhj
July 11th 2019, 11:07pm
AmericanBanking @AmericanBanking
-$1.22 EPS Expected for Mirati Therapeutics Inc $MRTX This Quarter https://t.co/Xno4qZ9Smj #stocks
July 11th 2019, 8:07pm
WeekHerald @WeekHerald
-$1.22 EPS Expected for Mirati Therapeutics Inc $MRTX This Quarter https://t.co/nSL6DlpwiC
July 11th 2019, 8:07pm
HeadlinesFin @HeadlinesFin
How Many Mirati Therapeutics, Inc. $MRTX's Analysts Are Bearish? https://t.co/FWkOMbeIP2
July 11th 2019, 2:07pm
Gambiste1 @Gambiste1
RT @OpenOutcrier: $MRTX (+0.9% pre) Mirati teams up with Novartis $NVS on doublet cancer therapy - SA https://t.co/IfyetbWBI8
July 10th 2019, 2:07pm
gerlach_d @gerlach_d
RT @TomSilver39: Leerink:" $MRTX Novartis Collaboration Suggests Validation for '849 Ahead of Initial Datasets; MRTX849 + TNO155 combines K…
July 10th 2019, 2:07pm
BioPharmaDive @BioPharmaDive
$NVS, for one, will partner on a combination study with $MRTX, which awaits the first clinical read-out for its clo… https://t.co/B86wmjxfD8
July 10th 2019, 1:07pm
TomSilver39 @TomSilver39
Leerink:" $MRTX Novartis Collaboration Suggests Validation for '849 Ahead of Initial Datasets; MRTX849 + TNO155 com… https://t.co/Vf5aNbqzfK
July 10th 2019, 11:07am
traderchicks @traderchicks
$MRTX shorts trying hard. and it's working
July 10th 2019, 10:07am
OpenOutcrier @OpenOutcrier
$MRTX (+0.9% pre) Mirati teams up with Novartis $NVS on doublet cancer therapy - SA https://t.co/IfyetbWBI8
July 10th 2019, 8:07am
TranscriptDaily @TranscriptDaily
Brokerages Set Mirati Therapeutics Inc $MRTX Target Price at $95.05 https://t.co/jvGG49HyJt
July 10th 2019, 8:07am
1stOncology @1stOncology
#Mirati Announces Clinical Collaboration to Evaluate #MRTX849 in Combination with #SHP2Inhibitor #TNO155 $MRTX https://t.co/7cGE1iGVNc
July 10th 2019, 8:07am
TranscriptDaily @TranscriptDaily
Brokerages Set Mirati Therapeutics Inc $MRTX Target Price at $95.05 https://t.co/HKADIPFj81
July 10th 2019, 7:07am
Gambiste1 @Gambiste1
RT @MarketCurrents: $MRTX $NVS - Mirati teams up with Novartis on doublet cancer therapy https://t.co/JEHwG3MbQt
July 10th 2019, 2:07am
AlertTrade @AlertTrade
RT @Briefingcom: $MRTX: Mirati Therapeutics announces clinical collaboration with Novartis (NVS) to evaluate MRTX849 in combination... http…
July 9th 2019, 6:07pm
Briefingcom @Briefingcom
$MRTX: Mirati Therapeutics announces clinical collaboration with Novartis (NVS) to evaluate MRTX849 in combination.… https://t.co/MPxXYf315E
July 9th 2019, 6:07pm
HottestStockNow @HottestStockNow
$MRTX, $NVS to Evaluate Combo MRTX849 + TNO155 in patients with advanced solid tumors that harbor KRAS G12C mutatio… https://t.co/wi36vfi09T
July 9th 2019, 5:07pm
newswithvalue @newswithvalue
$MRTX: Mirati Announces Clinical Collaboration to Evaluate MRTX849 in …: https://t.co/VDvBgCNc2u
July 9th 2019, 5:07pm
newswelldone @newswelldone
$MRTX $NVS: Mirati teams up with Novartis on doublet cancer therapy: https://t.co/rfAbiD6svT
July 9th 2019, 5:07pm
NedPagliarulo @NedPagliarulo
$MRTX working with $NVS on a non-exclusive collab pairing KRAS inhibitor '849 with the pharma's SHP2 inhibitor in s… https://t.co/lsTrxdGC86
July 9th 2019, 4:07pm
Hall8Jack @Hall8Jack
RT @syinvesting: $MRTX announces clinical collab with $NVS to evaluate combo of MRTX849 with SHP2 inhibitor. https://t.co/MbXCsritNj
July 9th 2019, 4:07pm
MarketCurrents @MarketCurrents
$MRTX $NVS - Mirati teams up with Novartis on doublet cancer therapy https://t.co/JEHwG3MbQt
July 9th 2019, 4:07pm
syinvesting @syinvesting
$MRTX announces clinical collab with $NVS to evaluate combo of MRTX849 with SHP2 inhibitor. https://t.co/MbXCsritNj
July 9th 2019, 4:07pm
st_swing @st_swing
ShadowTrader Swing Trader Advisory - $MRTX - Short the Stock https://t.co/HBFi4PQD5y
July 9th 2019, 3:07pm
SeekingAlpha @SeekingAlpha
$MRTX - Mirati Therapeutics Still Has Room To Grow https://t.co/s8qucJ8wQz
July 9th 2019, 11:07am
alphabyday @alphabyday
$MRTX Long is wrong. Market shifted to Structural Short Monday Jul 1, 8:30 am. Institutions followed later that mor… https://t.co/8vPXVXmlfd
July 8th 2019, 9:07pm
WeekHerald @WeekHerald
Mirati Therapeutics $MRTX Downgraded to “Sell” at Zacks Investment Research https://t.co/AwJHZ3ou9b
July 7th 2019, 6:07am
ThisLincolnian @ThisLincolnian
Mirati Therapeutics $MRTX Downgraded to “Sell” at Zacks Investment Research https://t.co/WzNS7MmyK2
July 7th 2019, 5:07am
Gambiste1 @Gambiste1
RT @msmoneymoves: One of our recent pieces by @stangbangbangUF overviewed tumor agnostic players with a focus on Mirati ( $mrtx )...who els…
July 6th 2019, 1:07pm
msmoneymoves @msmoneymoves
One of our recent pieces by @stangbangbangUF overviewed tumor agnostic players with a focus on Mirati ( $mrtx )...w… https://t.co/90JvwAGYqi
July 6th 2019, 11:07am
macondailynews @macondailynews
Mirati Therapeutics $MRTX Cut to Sell at Zacks Investment Research https://t.co/NyxMYhOoKr
July 6th 2019, 7:07am
stockmktgenius @stockmktgenius
$MRTX Mirati Therapeutics, Inc. Top stock up 242% from low. Close: 107.07 VolvsAvg: 0.51 Liq: $39M https://t.co/9N6zhpHCmr
July 5th 2019, 6:07pm
AmericanBanking @AmericanBanking
Mirati Therapeutics Inc $MRTX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/nnHVENMkfN #stocks
July 5th 2019, 8:07am
TickerReport @TickerReport
Mirati Therapeutics $MRTX Downgraded by Zacks Investment Research https://t.co/MwssFV2cZ8
July 5th 2019, 5:07am
dispatchtribune @dispatchtribune
Zacks Investment Research Downgrades Mirati Therapeutics $MRTX to Sell https://t.co/7N2gCTvoXi
July 5th 2019, 4:07am
stockmktgenius @stockmktgenius
$MRTX Mirati Therapeutics, Inc. Top stock up 242% from low. Close: 109.60 VolvsAvg: 0.31 Liq: $25M https://t.co/9N6zhpHCmr
July 3rd 2019, 6:07pm
Gambiste1 @Gambiste1
RT @alphabyday: $MRTX Nice Long Day trade pocketed again today thanks to Idiot Rampers. Great Entry on moated Puts for when risk inversion…
July 3rd 2019, 6:07pm
Gambiste1 @Gambiste1
RT @alphabyday: $MRTX Thanks again Idiot Rampers. Pocketed your money yesterday, will do so today, next week, next month. Why? You trade wi…
July 3rd 2019, 6:07pm
alphabyday @alphabyday
$MRTX Nice Long Day trade pocketed again today thanks to Idiot Rampers. Great Entry on moated Puts for when risk in… https://t.co/E5m9QFdtHM
July 3rd 2019, 1:07pm
alphabyday @alphabyday
$MRTX Thanks again Idiot Rampers. Pocketed your money yesterday, will do so today, next week, next month. Why? You… https://t.co/qYKjlesqhf
July 3rd 2019, 8:07am
stockmktgenius @stockmktgenius
$MRTX Mirati Therapeutics, Inc. Top stock up 232% from low. Close: 106.33 VolvsAvg: 0.51 Liq: $41M https://t.co/9N6zhpHCmr
July 2nd 2019, 9:07pm
XBIObserver @XBIObserver
RT @zbiotech: normalized EV appreciation over the past yr, no comment required $MRTX $ARQL https://t.co/CQnx6gx4Yp
July 2nd 2019, 11:07am
zbiotech @zbiotech
normalized EV appreciation over the past yr, no comment required $MRTX $ARQL https://t.co/CQnx6gx4Yp
July 2nd 2019, 10:07am
newswelldone @newswelldone
$MRTX $TEVA: The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To …: https://t.co/BTHFHxfdES
July 2nd 2019, 7:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.